Global Patent Index - EP 1094810 A1

EP 1094810 A1 2001-05-02 - USE OF PRENYLTRANSFERASE INHIBITORS FOR PREPARING A MEDICINE FOR TREATING PATHOLOGIES RESULTING FROM HETEROTRIMERIC G PROTEIN MEMBRANE FIXATION

Title (en)

USE OF PRENYLTRANSFERASE INHIBITORS FOR PREPARING A MEDICINE FOR TREATING PATHOLOGIES RESULTING FROM HETEROTRIMERIC G PROTEIN MEMBRANE FIXATION

Title (de)

VERWENDUNG VON PRENYLTRANSFERASE-INHIBITOREN ZUR HERSTELLUNG EINES ARZNEIMITTELS ZUR BEHANDLUNG VON KRANKHEITEN DIE, DURCH MEMBRANISCHE BEFESTIGUNG DER HETEROTRIMERISCHE-G-PROTEIN ENTSTEHEN

Title (fr)

UTILISATION D'INHIBITEURS DE PRENYLTRANSFERASES POUR PREPARER UN MEDICAMENT DESTINE A TRAITER LES PATHOLOGIES QUI RESULTENT DE LA FIXATION MEMBRANAIRE DE LA PROTEINE G HETEROTRIMERIQUE

Publication

EP 1094810 A1 (FR)

Application

EP 99929396 A

Priority

  • FR 9901611 W
  • FR 9808730 A

Abstract (en)

[origin: FR2780892A1] The invention concerns the use of prenyltransferase inhibitors for preparing a medicine for treating pathologies resulting from prenylation of the gamma subunit of G protein. Said diseases comprise in particular diseases related to the following biological functions or disorders: smell, taste, light perception, neurotransmission, neurodegeneration, endocrine and exocrine gland functioning, autocrine and paracrine regulation, blood pressure, embryogenesis, viral infection, immunological functions, diabetes and obesity.

IPC 1-7 (main, further and additional classification)

A61K 31/425; A61K 31/215; A61K 31/47; A61K 31/535; A61K 31/55; A61K 31/66; A61K 31/445; A61K 31/42; A61K 31/495

IPC 8 full level (invention and additional information)

C07D 277/06 (2006.01); A61K 31/198 (2006.01); A61K 31/223 (2006.01); A61K 31/4178 (2006.01); A61K 31/423 (2006.01); A61K 31/426 (2006.01); A61K 31/4427 (2006.01); A61K 31/4545 (2006.01); A61K 31/4709 (2006.01); A61K 31/495 (2006.01); A61K 31/4985 (2006.01); A61K 31/5377 (2006.01); A61K 31/5513 (2006.01); A61K 31/662 (2006.01); A61K 38/00 (2006.01); A61K 45/00 (2006.01); A61P 1/12 (2006.01); A61P 3/04 (2006.01); A61P 3/10 (2006.01); A61P 5/00 (2006.01); A61P 9/00 (2006.01); A61P 15/00 (2006.01); A61P 25/02 (2006.01); A61P 25/28 (2006.01); A61P 31/04 (2006.01); A61P 31/12 (2006.01); A61P 31/18 (2006.01); A61P 37/02 (2006.01); A61P 43/00 (2006.01); C07D 241/04 (2006.01); C07D 401/06 (2006.01); C07D 403/06 (2006.01); C07D 513/04 (2006.01)

CPC (invention and additional information)

A61K 38/005 (2013.01); Y02A 50/471 (2018.01)

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

EPO simple patent family

FR 2780892 A1 20000114; FR 2780892 B1 20010817; AU 4622499 A 20000201; CA 2337261 A1 20000120; EP 1094810 A1 20010502; JP 2002520284 A 20020709; NO 20010030 A 20010108; NO 20010030 D0 20010103; WO 0002558 A1 20000120

INPADOC legal status


2007-10-17 [18W] APPLICATION WITHDRAWN

- Effective date: 20070810

2004-01-28 [17Q] FIRST EXAMINATION REPORT

- Effective date: 20031212

2001-05-02 [17P] REQUEST FOR EXAMINATION FILED

- Effective date: 20010208

2001-05-02 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A1

- Designated State(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE